SEC Form 4/A · accession 0001415889-18-000770
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Frank L Jaksch Jr.
Officer — CEO · Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 201,557 | D | ||
| Common Stock | holding | — | — | — | 2,075,052 | I | By Black Sheep, FLP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being filed to amend the Form 4 filed on May 16, 2018. The purchases of common stock reported on such Form 4 did not in fact occur for the Reporting Person's account. The Reporting Person currently owns only the number of shares of common stock reflected in Column 5 of Table I.